The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy
Abstract
Background—: Whether morphological abnormalities of the mitral valve represent part of the hypertrophic cardiomyopathy (HCM) disease process is unresolved. Therefore, we applied cardiovascular magnetic resonance to characterize mitral valve morphology in a large HCM cohort. Methods and Results—: Cine cardiac magnetic resonance images were obtained in 172 HCM patients (age, 42±18 years; 62% men) and 172 control subjects. In addition, 15 HCM gene-positive/phenotype-negative relatives were studied. Anterior mitral leaflet (AML) and posterior mitral leaflet lengths were greater in HCM patients than in control subjects (26±5 versus 19±5 mm, P <0.001; and 14±4 versus 10±3 mm, P <0.001, respectively), including 59 patients (34%) in whom AML length alone, posterior mitral leaflet length alone, or both were particularly substantial (>2 SDs above controls). Leaflet length was increased compared with controls in virtually all HCM age groups, including young patients 15 to 20 years of age (AML, 26±5 versus 21±4 mm; P =0.0002) and those ≥60 years of age (AML, 26±4 versus 19±2 mm; P <0.001). No relation was evident between mitral leaflet length and LV thickness or mass index ( P =0.09 and P =0.16, respectively). A ratio of AML length to LV outflow tract diameter of >2.0 was associated with subaortic obstruction ( P =0.001). In addition, AML length in 15 genotype-positive relatives without LV hypertrophy exceeded that of matched control subjects (21±3 versus 18±3 mm; P <0.01). Conclusions—: In HCM, mitral valve leaflets are elongated independently of other disease variables, likely constituting a primary phenotypic expression of this heterogeneous disease, and are an important morphological abnormality responsible for LV outflow obstruction in combination with small outflow tract dimension. These findings suggest a novel role for cardiac magnetic resonance in the assessment of HCM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Self-citationMaron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., Ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,578
Self-citationMaron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Self-citationHypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction
Maron, M. S., Olivotto, I., Zenovich, A. G., Link, M. S., Pandian, N. G., Kuvin, J. T., Nistri, S., Cecchi, F., Udelson, J. E., & Maron, B. J. (2006) · Circulation · doi:10.1161/circulationaha.106.644682 · Cited by 1,123
Self-citationThe Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,046
Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy
Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025050 · Cited by 782
Self-citationHypertrophic Cardiomyopathy: Clinical Spectrum and Treatment
Wigle, E. D., Rakowski, H., Kimball, B. P., & Williams, W. G. (1995) · Circulation · doi:10.1161/01.cir.92.7.1680 · Cited by 778
BRAUNWALD, E., LAMBREW, C. T., ROCKOFF, S. D., ROSS, J., & MORROW, A. G. (1964) · Circulation · doi:10.1161/01.cir.29.5s4.iv-3 · Cited by 758
Harris, K. M., Spirito, P., Maron, M. S., Zenovich, A. G., Formisano, F., Lesser, J. R., Mackey-Bojack, S., Manning, W. J., Udelson, J. E., & Maron, B. J. (2006) · Circulation · doi:10.1161/circulationaha.105.583500 · Cited by 671
Self-citationUtility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy
Rickers, C., Wilke, N. M., Jerosch-Herold, M., Casey, S. A., Panse, P., Panse, N., Weil, J., Zenovich, A. G., & Maron, B. J. (2005) · Circulation · doi:10.1161/circulationaha.104.507723 · Cited by 584
Self-citation
Cited by
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Marian, A. J., & Braunwald, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311059 · Cited by 1,403
Maron, B. J., & Maron, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60397-3 · Cited by 1,231
Self-citationOmmen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.044 · Cited by 994
Self-citationOmmen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807
Genetics of Hypertrophic Cardiomyopathy After 20 Years
Maron, B. J., Maron, M. S., & Semsarian, C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.068 · Cited by 701
Self-citationMaron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.003 · Cited by 652
Self-citation2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.045 · Cited by 643
Self-citationDiagnosis and Evaluation of Hypertrophic Cardiomyopathy
Maron, B. J., Desai, M. Y., Nishimura, R. A., Spirito, P., Rakowski, H., Towbin, J. A., Rowin, E. J., Maron, M. S., & Sherrid, M. V. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.002 · Cited by 637
Self-citationWriting Committee Members, Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000937 · Cited by 605
Self-citationMaron, B. J., Udelson, J. E., Bonow, R. O., Nishimura, R. A., Ackerman, M. J., Estes, N. A. M., Cooper, L. T., Link, M. S., & Maron, M. S. (2015) · Circulation · doi:10.1161/cir.0000000000000239 · Cited by 448
Self-citationMitral valve disease—morphology and mechanisms
Levine, R. A., Hagége, A. A., Judge, D. P., Padala, M., Dal-Bianco, J. P., Aikawa, E., Beaudoin, J., Bischoff, J., Bouatia-Naji, N., Bruneval, P., et al. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.161 · Cited by 386
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · JACC · doi:10.1016/j.jacc.2024.02.014 · Cited by 382
Pelliccia, A., Caselli, S., Sharma, S., Basso, C., Bax, J. J., Corrado, D., D’Andrea, A., D’Ascenzi, F., Di Paolo, F. M., Edvardsen, T., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx532 · Cited by 368
Olivotto, I., Cecchi, F., Poggesi, C., & Yacoub, M. H. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.967026 · Cited by 352
Self-citation2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., Mahrholdt, H., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0212 · Cited by 341
Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
Maron, M. S. (2012) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-14-13 · Cited by 306
Self-citationCardim, N., Galderisi, M., Edvardsen, T., Plein, S., Popescu, B. A., D'Andrea, A., Bruder, O., Cosyns, B., Davin, L., Donal, E., et al. (2015) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jeu291 · Cited by 284
The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy
Sherrid, M. V., Balaram, S., Kim, B., Axel, L., & Swistel, D. G. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.071 · Cited by 276
Hypertrophic obstructive cardiomyopathy
Veselka, J., Anavekar, N. S., & Charron, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31321-6 · Cited by 257
How to Image Hypertrophic Cardiomyopathy
Maron, M. S., Rowin, E. J., & Maron, B. J. (2017) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005372 · Cited by 70
Self-citation
Metadata
- Authors
- Maron, M. S., Olivotto, I., Harrigan, C., Appelbaum, E., Gibson, C. M., Lesser, J. R., Haas, T. S., Udelson, J. E., Manning, W. J., & Maron, B. J.
- Venue
- Circulation
- Published
- 2011-07-05
- Volume
- 124
- Issue
- 1
- Pages
- 40-47
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2051967821
- Cited by
- 451
- References
- 42
- FWCI
- 19.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.